DarshanTalks Podcast
Welcome to DarshanTalks!
We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!
Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do.
We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.
DarshanTalks Podcast
Safe or Just "Not Dirty"? The Regulatory Gamble of Compounded Drugs
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode, Darshan Kulkarni breaks down the staggering legal difference between the branded drugs you know (like Mounjaro) and the compounded versions flooding the market. Using a brilliant "Coke vs. RC Cola" analogy, we explore why "clean vats" aren't the same as "proven science." If you are a patient, a provider, or a legal professional in the life sciences space, you need to understand the four pillars of FDA approval—and why some of the most popular drugs on the market today are legally allowed to skip the hardest parts
www.kulkarnilawfirm.com
Ever notice how generic cola tastes almost like coke? But it costs way less. In soda aisle, that's fine. Pharmacy, it's a massive regulatory gamble. Let's talk about why your weight loss deal might be missing more than just its brand name. Think of Coke as a branded drug, like Manjaro. Before it hits the shelf, it has to prove four things to the FDA. It has to prove that it's two and that it's not two. So it has to prove to the FDA that it's safe and that it's efficacious. Efficacious means that it does what it says it does. It also has to prove that it's not the following two things. That it's not adulterated and it's not misbranded. So adulteration, think of it as basically no dirt in like the vac that they're making it, and misbranded says that the label itself is honest. Branded drugs spend billions to check all four boxes. I look at compounded drugs. They are sort of the RC colo of the industry, but with a twist. Legally, they're only required to prove that the that they are not adulterated. They prove that their vats are clean, but they'd never do these clinical tests to prove safety or efficacy for their specific mix.
SPEAKER_00Enjoying our content? We'd love to hear more. Please like, comment, share, and find more.
DarshanThey're skipping the hardest, most expensive parts of the FDA process. And that's not necessarily a bad thing. It actually works for many cases, for example, when there are shortages. But then there's misbranding. If Coke lied about its ingredients, they'd be sued into oblivion. Branded drugs have strict rules on what they can claim. Compounding pharmacies often use marketing. If you use the same standard, they'd be considered misbranded. And that's why they're cheaper. Taking a shortcut through the rules does not mean they're not safe. It means there's no law that forces them to prove it. Outside like the FTC rules, which are a lot simpler. In the soda world, a knockoff is just bad taste. In pharma, a knockoff is a drug that has not been proven that it works or that it won't hurt you. So are you buying the science or are you buying the liquid? Let me know in the comments. Call, click, or email.
